Astera Labs (NASDAQ: ALAB) gave the market everything it could ask for in the Q2 release, including a trigger for lower share prices to open what may be the final opportunity to buy this stock below $360.
The earnings release revealed acceleration, outperformance, margin strength, and momentum, all of which point to higher stock prices over time.
